NCT03250091 Surveillance of Patients With Precancerous Lesions of the Stomach
| NCT ID | NCT03250091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Latvia |
| Condition | Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2017-06-19 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2017-06-19 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project will aim to identify and determine subgroups of patients with different risks of progression to gastric cancer and to assess appropriate follow-up intervals. Implementing risk stratification only high risk individuals will be offered and performed endoscopic surveillance.
Eligibility Criteria
Inclusion Criteria: Patients undergoing upper endoscopy Motivation to participate in the study Signed consent Exclusion Criteria: Known gastric cancer Unwillingness or inability to co-operate
Contact & Investigator
Marcis Leja, Prof.,PhD
STUDY DIRECTOR
Institute of Clinical and Preventive Medicine, University of Latvia
Frequently Asked Questions
Who can join the NCT03250091 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03250091 currently recruiting?
Yes, NCT03250091 is actively recruiting participants. Contact the research team at ikikuste@gmail.com for enrollment information.
Where is the NCT03250091 trial being conducted?
This trial is being conducted at Riga, Latvia.
Who is sponsoring the NCT03250091 clinical trial?
NCT03250091 is sponsored by University of Latvia. The principal investigator is Marcis Leja, Prof.,PhD at Institute of Clinical and Preventive Medicine, University of Latvia. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.